Op2Lysis
PrivateLast Round
Series A
Nov 4, 2024
Total Funding Raised
$12.55M
Company Overview
Op2Lysis is a biotechnology company that develops innovative medicines for the treatment of hemorrhagic stroke using its proprietary NANOp2Lysis® technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Op2Lysis Comparables
Compare Op2Lysis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioxodes | 86% | |
| Lys Therapeutics | 77% | |
| Basking Biosciences | 75% | |
Op2Lysis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 4, 2024 | ||||
| Grant | Jul 7, 2023 | ||||
| Accelerator | Oct 1, 2021 | ||||
| Early Funding | Dec 1, 2020 | ||||
| Seed | Apr 1, 2018 |
Key People
Founding team and executive leadership
Op2Lysis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Accelerator |
| Noshaq | Early Funding |
| WiSeed | Seed |
| Bpifrance | Grant |
| BeAngels | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2024
$29.16M Series A round completed.
- Jul 7, 2023
$1.65M grant received from Bpifrance.
Op2Lysis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Op2Lysis's valuation, stock price, and market status.